SEC 13F Intelligence

Managers / Q2 2023 · view latest →

HighVista Strategies LLC

CIK 0001335325 · 200 CLARENDON STREET, 50TH FLOOR, BOSTON, MA, 02116 · 617-406-6500

Reported Value
$219M
Q2 2023
Positions
134
Filings on Record
30
2019–present window
Filed
Aug 14, 2023
original filing

Summary

Highvista Strategies LLC reported $219M in U.S.-listed holdings across 134 positions for Q2 2023.

Its largest position, DBC, represents 14.9% of the portfolio.

Compared with Q1 2023, the fund opened 55 new positions and exited 29.

Portfolio Metrics

Turnover
+24.1%
vs prior filed quarter
Top-10 Concentration
+33.7%
share of reported value
Largest Position
+14.9%
Invesco Db Commdy Indx Trck
New / Exited
55 / 29
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $116MQ4 ’18Q1 ’19: $123MQ2 ’19: $195MQ3 ’19: $147MQ4 ’19: $132MQ4 ’19Q1 ’20: $108MQ2 ’20: $121MQ3 ’20: $137MQ4 ’20: $157MQ4 ’20Q1 ’21: $135MQ2 ’21: $141MQ3 ’21: $151MQ4 ’21: $126MQ4 ’21Q1 ’22: $157MQ2 ’22: $166MQ3 ’22: $175MQ4 ’22: $168MQ4 ’22Q1 ’23: $123MQ2 ’23: $219MQ3 ’23: $216MQ4 ’23: $276MQ4 ’23Q1 ’24: $280MQ2 ’24: $274MQ3 ’24: $290MQ4 ’24: $269MQ4 ’24Q1 ’25: $260MQ2 ’25: $272MQ3 ’25: $408MQ4 ’25: $388MQ4 ’25Q1 ’26: $362Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 66.4%ETP: 14.9%ADR: 8.6%Other: 8.5%MLP: 1.6%
  • Common Stock · 66.4% · $145M
  • ETP · 14.9% · $33M
  • ADR · 8.6% · $19M
  • Other · 8.5% · $19M
  • MLP · 1.6% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
WEPMAGELLAN MIDSTREAM PRTNRS LPNEW+55.9K55.9K+$3M$3M
AJRDEURAEROJET ROCKETDYNE HLDGS INCNEW+61.5K61.5K+$3M$3M
TXNMPNM RES INCNEW+69.9K69.9K+$3M$3M
INDIVIOR PLCNEW+130.0K130.0K+$3M$3M
OLMAOLEMA PHARMACEUTICALS INCNEW+292.3K292.3K+$3M$3M
IMRXIMMUNEERING CORPNEW+253.1K253.1K+$3M$3M
AMBRX BIOPHARMA INCNEW+153.4K153.4K+$3M$3M
ELVNENLIVEN THERAPEUTICS INCNEW+121.1K121.1K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2023

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1DBCINVESCO DB COMMDY INDX TRCKhistory →UNIT14.92%$33M1.44M
2MLTXMOONLAKE IMMUNOTHERAPEUTICShistory →CLASS A ORD3.03%$7M129.7K
3OPHTEURIVERIC BIO INChistory →COM2.51%$5M139.6K
4ATVIEURACTIVISION BLIZZARD INChistory →COM2.37%$5M61.5K
5VMWEURVMWARE INChistory →CL A COM2.21%$5M33.6K
6ACIALBERTSONS COS INChistory →COMMON STOCK1.88%$4M188.8K
7MSFTMICROSOFT CORPhistory →COM1.77%$4M11.4K
8CYMABAY THERAPEUTICS INCCOM1.70%$4M338.8K
9SGENUSDSEAGEN INChistory →COM1.67%$4M19.0K
10HORIZON THERAPEUTICS PUB LSHS1.64%$4M35.0K
11BKIEURBLACK KNIGHT INChistory →COM1.64%$4M60.1K
12AXSMAXSOME THERAPEUTICS INChistory →COM1.62%$4M49.4K
13WEPMAGELLAN MIDSTREAM PRTNRS LPhistory →COM UNIT RP LP1.59%$3M55.9K
14IMVTIMMUNOVANT INChistory →COM1.57%$3M180.3K
15AJRDEURAEROJET ROCKETDYNE HLDGS INChistory →COM1.54%$3M61.5K
16TXNMPNM RES INChistory →COM1.44%$3M69.9K
17INDIVIOR PLCORD1.42%$3M130.0K
18NUVLNUVALENT INChistory →COM1.39%$3M72.3K
19CRMSALESFORCE INChistory →COM1.36%$3M14.1K
20CHINOOK THERAPEUTICS INCCOM1.34%$3M76.0K
21APLSUSDAPELLIS PHARMACEUTICALS INChistory →COM1.26%$3M30.2K
22GOOGALPHABET INChistory →CAP STK CL C1.22%$3M22.0K
23IMCRIMMUNOCORE HLDGS PLChistory →ADS1.21%$3M44.1K
24OLMAOLEMA PHARMACEUTICALS INChistory →COM1.21%$3M292.3K
25VRDNVIRIDIAN THERAPEUTICS INChistory →COM1.18%$3M108.8K
26IMRXIMMUNEERING CORPhistory →CLASS A COM1.17%$3M253.1K
27COGTCOGENT BIOSCIENCES INChistory →COM1.17%$3M216.1K
28AMBRX BIOPHARMA INCSPONSORED ADS1.16%$3M153.4K
29LEGNLEGEND BIOTECH CORPhistory →SPONSORED ADS1.15%$3M36.4K
30ELVNENLIVEN THERAPEUTICS INChistory →COM1.13%$2M121.1K
31BCYCBICYCLE THERAPEUTICS PLChistory →SPONSORED ADS1.08%$2M92.4K
32X0M1XOMA CORP DELhistory →COM NEW1.03%$2M118.9K
33ACLXGBXARCELLX INCCOMMON STOCK0.91%$2M62.9K
34KARUNA THERAPEUTICS INCCOM0.90%$2M9.1K
35VVISA INCCOM CL A0.88%$2M8.1K
36RPTXREPARE THERAPEUTICS INCCOM0.80%$2M165.2K
37METAMETA PLATFORMS INCCL A0.77%$2M5.9K
38MAMASTERCARD INCORPORATEDCL A0.76%$2M4.2K
39JDJD.COM INCSPON ADR CL A0.72%$2M46.3K
40430TERNS PHARMACEUTICALS INCCOM0.72%$2M179.7K
41PTCPTC INCCOM0.63%$1M9.7K
42INTUINTUITCOM0.62%$1M3.0K
43AMZNAMAZON COM INCCOM0.61%$1M10.3K
44THESEUS PHARMACEUTICALS INCCOM0.58%$1M136.7K
45BILIBILIBILI INCSPONS ADS REP Z0.56%$1M80.9K
46XPOXPO INCCOM0.55%$1M20.3K
47DICE THERAPEUTICS INCCOM0.46%$1M21.6K
48WWEUSDWORLD WRESTLING ENTMT INCCL A0.44%$966,1428.9K
49BKNGBOOKING HOLDINGS INCCOM0.44%$964,018357
50APOAPOLLO GLOBAL MGMT INCCOM0.44%$957,51312.5K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$362M156May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$388M145Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$408M148Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$272M146Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$260M148May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$269M137Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$290M142Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$274M138Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$280M131May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$276M126Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$216M132Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$219M134Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$123M108May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$168M105Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$175M113Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$166M110Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$157M86May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$126M69Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$151M127Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$141M116Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$135M125May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$157M117Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$137M113Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$121M100Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$108M65May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$132M119Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$147M126Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$195M108Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$123M112May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$116M113Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.